These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32546508)

  • 1. Genetics of hypertrophic cardiomyopathy: what is the next step?
    Kuusisto J
    Heart; 2020 Sep; 106(17):1291-1292. PubMed ID: 32546508
    [No Abstract]   [Full Text] [Related]  

  • 2. My approach to clinical management of hypertrophic cardiomyopathy.
    Maron MS
    Trends Cardiovasc Med; 2014 Oct; 24(7):314-5. PubMed ID: 25218674
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertrophic cardiomyopathy: management issues in the new millennium.
    Thaman R; Firoozi S; Hamid MS; McKenna WJ
    Curr Cardiol Rep; 2002 May; 4(3):226-32. PubMed ID: 11960592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Perspective on Personalized Therapies in Hypertrophic Cardiomyopathy.
    Goldspink PH; Warren CM; Kitajewski J; Wolska BM; Solaro RJ
    J Cardiovasc Pharmacol; 2021 Mar; 77(3):317-322. PubMed ID: 33298734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in understanding hypertrophic cardiomyopathy.
    Mohiddin S; Fananapazir L
    Hosp Pract (1995); 2001 May; 36(5):23-5, 29-30, 33-6. PubMed ID: 11361156
    [No Abstract]   [Full Text] [Related]  

  • 6. State-of-the-art management of hypertrophic cardiomyopathy in children.
    Berger S; Dhala A; Dearani JA
    Cardiol Young; 2009 Nov; 19 Suppl 2():66-73. PubMed ID: 19857352
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical predictors of informative genetic testing in hypertrophic cardiomyopathy.
    Naraen A; McKay V; Shaw M; Modi S; Fairbairn T; Somauroo J; Todd D; Cooper R
    Eur J Prev Cardiol; 2020 May; 27(7):777-779. PubMed ID: 30348007
    [No Abstract]   [Full Text] [Related]  

  • 8. Current management of hypertrophic cardiomyopathy.
    Golledge P; Knight CJ
    Hosp Med; 2001 Feb; 62(2):79-82. PubMed ID: 11236621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MY APPROACH to the athlete with hypertrophic cardiomyopathy.
    Lampert R
    Trends Cardiovasc Med; 2019 Jul; 29(5):312. PubMed ID: 30928314
    [No Abstract]   [Full Text] [Related]  

  • 10. Re-examining family history of sudden death as a risk marker in hypertrophic cardiomyopathy.
    Siontis KC; Ommen SR; Maron MS; Maron BJ
    Heart Rhythm; 2024 Oct; 21(10):1838-1842. PubMed ID: 38909716
    [No Abstract]   [Full Text] [Related]  

  • 11. A good idea: a physician's perspective on genetic counseling for hypertrophic cardiomyopathy.
    Patterson C
    J Cardiovasc Transl Res; 2009 Dec; 2(4):508-9. PubMed ID: 20560009
    [No Abstract]   [Full Text] [Related]  

  • 12. Update on hypertrophic cardiomyopathy.
    Marian AJ
    Tex Heart Inst J; 2010; 37(3):322-3. PubMed ID: 20548812
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypertrophic Cardiomyopathy, Athlete's Heart, or Both: A Case of Hypertrophic Cardiomyopathy Regression.
    Kebed KY; Bos JM; Anavekar NS; Mulvagh SL; Ackerman MJ; Ommen SR
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003312. PubMed ID: 26162782
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic Cardiomyopathy.
    Murphy SL; Anderson JH; Kapplinger JD; Kruisselbrink TM; Gersh BJ; Ommen SR; Ackerman MJ; Bos JM
    J Cardiovasc Transl Res; 2016 Apr; 9(2):153-61. PubMed ID: 26914223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden death in hypertrophic cardiomyopathy.
    Watkins H
    N Engl J Med; 2000 Feb; 342(6):422-4. PubMed ID: 10666434
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic counseling and testing for hypertrophic cardiomyopathy: the pediatric perspective.
    Demo EM; Skrzynia C; Baxter S
    J Cardiovasc Transl Res; 2009 Dec; 2(4):500-7. PubMed ID: 20560008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden death risk stratification in hypertrophic cardiomyopathy: genetic and clinical bases.
    Piva e Mattos B
    Arq Bras Cardiol; 2006 Sep; 87(3):391-9. PubMed ID: 17057942
    [No Abstract]   [Full Text] [Related]  

  • 18. A simple algorithm for a clinical step-by-step approach in the management of hypertrophic cardiomyopathy.
    Efthimiadis G; Zegkos T; Parcharidou D; Ntelios D; Panagiotidis T; Gossios T; Karvounis H
    Future Cardiol; 2021 Nov; 17(8):1395-1405. PubMed ID: 33615852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy: evaluation and treatment of patients at high risk for sudden death.
    Fananapazir L; McAreavey D
    Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 2):478-501. PubMed ID: 9058851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy: infants, children, and adolescents.
    Maskatia SA
    Congenit Heart Dis; 2012; 7(1):84-92. PubMed ID: 22222117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.